LRLisa B. Rokoff

Lisa B. Rokoff

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lisa B. Rokoff has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Abby F. Fleisch

    9 shared publications
  • Emily Oken

    6 shared publications
  • Sheryl L. Rifas-Shiman

    6 shared publications
  • Antonia M. Calafat

    Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia

    5 shared publications
  • Julianne Cook Botelho

    Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia

    4 shared publications
  • Abby F. Fleisch

    Tufts University School of Medicine, 145 Harrison Ave, Suite 813, 02111, Boston, MA, USA; Center for Interdisciplinary Population and Health Research, MaineHealth Institute for Research, 1 Riverfront Plaza, Fl 4, 04092, Westbrook, ME, USA; Pediatric Endocrinology and Diabetes, Maine Medical Center, 887 Congress St. #100, 04102, Portland, ME, USA

    3 shared publications

Latest Publications

  • Open Access

    Childhood Metabolomic Profiles of Phthalate and Phthalate Replacement Exposure in the Project Viva Cohort

    by Dennis Khodasevich, Sheryl L. Rifas-Shiman, Lisa B. Rokoff, Marie-France Hivert, Wei Perng, Izzuddin M. Aris, Emily Oken, Abby F. Fleisch, Andres Cardenas

  • Associations of per- and polyfluoroalkyl substances (PFAS) with muscle mass and function in women in midlife

    by Lisa B. Rokoff, Sheryl L. Rifas-Shiman, Pi-I D. Lin, Andres Cardenas, Julianne Cook Botelho, Antonia M. Calafat, Ami R. Zota, Tamarra James-Todd, Diane R. Gold, Abby F. Fleisch, et al.

    Background: Per- and polyfluoroalkyl substances (PFAS) are ubiquitous chemicals that disrupt hormonal and inflammatory pathways and may thereby influence body composition. Reduced muscle mass increases risk of frailty, a condition disproportionately affecting women. Methods: In the Project Viva cohort (N = 551), we assessed outcomes in midlife (2017–2024, mean age 50.7 years) including appendicular lean mass index (ALMI), a marker of muscle mass measured via dual X-ray absorptiometry, and plasma concentrations of PFAS at enrollment in pregnancy (1999–2002) and in midlife. We used covariate-adjusted linear regression of individual PFAS and the PFAS burden score and quantile g-computation (qgcomp) mixture models to examine PFAS-ALMI associations, and we explored effect modification by menopausal status, diet, and physical activity at midlife. In secondary analyses, we evaluated associations of midlife PFAS with midlife muscle function measures, and pregnancy PFAS with midlife ALMI. Results: Mean (standard deviation) ALMI was 6.93 (1.11) kg/m 2 , and PFAS concentrations compared well with those from contemporaneous National Health and Nutrition Examination Survey cycles. Women with higher concentrations of perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), and the qgcomp PFAS mixture in midlife had lower ALMI (e.g., −0.04 [95% confidence interval = −0.09, −0.0001]; kg/m 2 per 0.2 ng/mL increment in PFNA). There was no consistent evidence of effect modification by menopausal status, diet, or physical activity. Associations of midlife PFAS with muscle function (grip strength, physical performance), and pregnancy PFAS with midlife ALMI, were null or positive. Conclusion: Women with higher plasma concentrations of select PFAS had small decrements in ALMI, but muscle function measures were unchanged or slightly better.

  • Correction to “Predictors of Serum Per- and Polyfluoroalkyl Substances (PFAS) Concentrations in a Rural Agricultural Community Affected by Biosolids Application”

    by Lisa B. Rokoff, Katherine Senechal, Megan E. Romano, Julianne Cook Botelho, Antonia M. Calafat, Rachel Criswell, Abby F. Fleisch

  • Predictors of Serum Per- and Polyfluoroalkyl Substances (PFAS) Concentrations in a Rural Agricultural Community Affected by Biosolids Application

    by Lisa B. Rokoff, Katherine Senechal, Megan E. Romano, Julianne Cook Botelho, Antonia M. Calafat, Rachel Criswell, Abby F. Fleisch

    Human exposure pathways to PFAS from contaminated biosolids applied as fertilizers are not well understood. In the Maine Biosolids Study, we examined predictors of serum PFAS concentrations in adults (N = 144) living near sites of historical agricultural biosolids application. All participants had PFAS concentrations measured in their private drinking well water by the Maine Department of Environmental Protection from 2020 to 2023. In late 2023, we measured serum PFAS concentrations and administered a survey on water-related, occupational/recreational, residential, local food intake, and sociodemographic/health characteristics. We used multivariable linear mixed-effects models to examine associations of each predictor with serum concentrations of perfluorohexanesulfonic acid (PFHxS), perfluorooctanesulfonic acid, perfluorooctanoic acid (PFOA), perfluorononanoic acid, and perfluorodecanoic acid. Daily PFAS water intake was the strongest predictor of each serum PFAS, explaining between 22% (PFHxS) and 40% (PFOA) of the variance. Males, postmenopausal females, frequent consumers of local eggs, and those who worked with biosolids on a farm or in another capacity also had higher concentrations of select PFAS than other participants. Together, the predictors studied explained 38–52% of the total variance in serum concentration of each PFAS. Future studies will help further investigate local egg consumption and working with biosolids to inform mitigation strategies in biosolid-impacted communities.

  • Open Access

    Psychosocial distress among individuals residing in a rural PFAS-contaminated community

    by Elizabeth Scharnetzki, Lisa B. Rokoff, Katherine Senechal, Michelle Bosquet Enlow, Abby F. Fleisch, Rachel Criswell


  • Open Access

    Concentrations of per- and polyfluoroalkyl substances (PFAS) in private well drinking water and serum of individuals exposed to PFAS through biosolids: The Maine Biosolids Study

    by Rachel Criswell, Katherine Senechal, Anne M. Mullin, Antonia M. Calafat, Julianne Cook Botelho, Lisa B. Rokoff, Abby F. Fleisch


  • Open Access

    Mid-Childhood Plasma Concentrations of Per- and Polyfluoroalkyl Substances, Modifiable Lifestyle Factors, and Bone Mineral Density Through Late Adolescence

    by Lisa B. Rokoff, Sheryl L. Rifas-Shiman, Izzuddin M. Aris, Pi-I D. Lin, Clifford J. Rosen, Antonia M. Calafat, Catherine M. Gordon, Emily Oken, Abby F. Fleisch

    There is limited research on associations of per- and polyfluoroalkyl substances (PFAS) with areal bone mineral density (aBMD) through adolescence and whether bone-strengthening factors ameliorate effects. In the Project Viva cohort (N = 484; 50% female), we used sex-stratified linear regression and quantile g-computation mixture models to examine associations of mid-childhood (median: 7.8 years; 2007-2010) plasma PFAS concentrations with a dual-energy X-ray absorptiometry total-body aBMD Z-score in early and late adolescence (median: 12.9 and 17.6 years, respectively). We explored stratum-specific estimates by parent/self-reported physical activity and dairy intake. Using linear mixed models, we evaluated associations with aBMD accrual from mid-childhood through late adolescence. Females with higher perfluorooctanoate (PFOA) and perfluorodecanoate (PFDA) had lower early adolescent aBMD Z-score [e.g., β(95%CI)] per doubling PFOA: -0.19(-0.41, 0.03)]. Youth with higher PFOA and PFDA had lower late adolescent aBMD Z-score, but CIs were wide [e.g., PFOA: females, -0.12(-0.40, 0.16); males, -0.10(-0.42, 0.21)]. Mixture models generally corroborated single PFAS results, and in linear mixed models, females with higher PFAS concentrations, and males with higher PFOA, had slower aBMD accrual. Less active males with higher PFOA, PFDA, and the PFAS mixture had lower late adolescent aBMD Z-score. Some PFAS appeared more negatively associated with the aBMD Z-score among those who consumed less dairy, but there was not consistent evidence of effect modification. Exposure to select PFAS may affect bone accrual through adolescence, with possible resilience conferred by greater physical activity and dairy intake.


  • Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva

    by Lisa B. Rokoff, Jordyn T. Wallenborn, Maria H. Harris, Sheryl L. Rifas-Shiman, Rachel Criswell, Megan E. Romano, Jessica G. Young, Antonia M. Calafat, Emily Oken, Sharon K. Sagiv, et al.


  • Associations of urinary metabolite concentrations of phthalates and phthalate replacements with body composition from mid-childhood to early adolescence

    by Lisa B. Rokoff, Shravanthi M. Seshasayee, Jenny L. Carwile, Sheryl L. Rifas-Shiman, Julianne Cook Botelho, Catherine M. Gordon, Russ Hauser, Tamarra James-Todd, Jessica G. Young, Clifford J. Rosen, et al.


  • Associations of Prenatal Chemical and Nonchemical Stressors with Early-Adulthood Anxiety and Depressive Symptoms

    by Lisa B. Rokoff, Brent A. Coull, Michelle Bosquet Enlow, Susan A. Korrick

    Prenatal exposure to environmental chemicals may increase risk of childhood internalizing problems, but few studies have explored the potential for longer-term consequences of such exposures. We evaluated associations between prenatal organochlorine and metal levels and early adulthood internalizing symptoms, considering whether sociodemographic/nonchemical stressors modified these associations. Participants were 209 young adults, born (1993-1998) to mothers residing in or near New Bedford, Massachusetts. As part of the early-adult assessment, self-reported anxiety (7-item Generalized Anxiety Disorder scale) and depressive (8-item Patient Health Questionnaire) symptoms (≥10: elevated symptoms) were ascertained. We previously analyzed levels of cord serum organochlorines [hexachlorobenzene, dichlorodiphenyldichloroethylene (p,p'-DDE), polychlorinated biphenyls (ΣPCB4: sum of congeners 118, 138, 153, 180)] and whole blood lead shortly after participants' birth, and levels of cord whole blood manganese from archived samples at the time of the adolescent study visit. We used modified Poisson regression models and quantile g-computation, adjusting for sociodemographics, and explored whether biological sex, race/ethnicity (proxy for unmeasured consequences of racism), prenatal social disadvantage (assessed when participants were neonates), and quality of the home environment (assessed during adolescence) modified these associations. Participants were (mean±standard deviation) 22.1±1.5 y old, 76% Non-Hispanic White, and 67% female. Prenatal hexachlorobenzene, p,p'-DDE, and lead exposures were moderately associated with increased risk of elevated anxiety symptoms. There were strata-specific associations for prenatal social disadvantage and quality of home environment such that adverse associations of p,p'-DDE and lead and the overall mixture with anxiety and depressive symptoms were largely only evident in those with lower nonchemical stress [e.g., risk ratio and 95% confidence interval (CI) per doubling p,p'-DDE for anxiety: 1.54 (95% CI: 1.20, 1.99) in high-quality home environments and 0.77 (95% CI: 0.51, 1.16) in low-quality home environments]. Associations between prenatal hexachlorobenzene and p,p'-DDE and anxiety symptoms were stronger for underrepresented racial/ethnic group participants vs. Non-Hispanic Whites. We found minimal evidence for sex-specific effects, and no consistent associations with manganese or ΣPCB4. Prenatal organochlorine pesticides and lead exposure possibly increases risk of internalizing problems, particular anxiety symptoms, in young adults. Varying risk was observed by sociodemographic/nonchemical stressor strata, demonstrating the importance of considering interactions between chemical and other stressors. https://doi.org/10.1289/EHP11171.